(Q51599931)

7 April 2018

reason for preferred rank

title

Interaction between grapefruit juice and midazolam in humans* (English)

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

20 June 2024

Interaction between grapefruit juice and midazolam in humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628179

20 June 2024

1 reference

H. H. Kupferschmidt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628179

20 June 2024

H. R. Ha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628179

20 June 2024

W. H. Ziegler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628179

20 June 2024

P. J. Meier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628179

20 June 2024

S. Krähenbühl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628179

20 June 2024

language of work or name

English

0 references

publication date

1 July 1995

1 reference

7 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

7 April 2018

volume

58

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

page(s)

20-28

1 reference

7 April 2018

Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990068-3

Trough concentrations of cyclosporine in blood following administration with grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990068-3

Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990068-3

Relationship between plasma concentration and effect of midazolam after oral and intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990068-3

Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990068-3

Pharmacokinetics and bioavailability of midazolam in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990068-3

Interaction of citrus juices with felodipine and nifedipine

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin

20 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans

20 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics

20 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

20 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4.

20 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

Grapefruit juice and drugs. How significant is the interaction?

20 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

20 June 2024

Molecular Pharmacology

13

36

89

Kronbach T.

1989

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam

20 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

A potentially hazardous interaction between erythromycin and midazolam.

20 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

20 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

Determination of midazolam and its alpha-hydroxy metabolite in human plasma and urine by high-performance liquid chromatography.

20 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

20 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

The pharmacokinetics of midazolam in man.

20 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

First-pass elimination. Basic concepts and clinical consequences

20 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids

20 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90068-3

20 June 2024

Identifiers

1 reference

7 April 2018

1 reference

7 April 2018